Buscar
07/03/2026
From bile to vessels: linking obesity to endothelial dysfunction
Kraler, S, Vilahur, G, Kleinbongard, P. From bile to vessels: linking obesity to endothelial dysfunction. EUROPEAN HEART JOURNAL. 2026; 47(10)DOI:10.1093/eurheartj/ehaf957. PMID:41329862. IF:35.600(Q1/1D).
06/03/2026
Impact of glycemic optimization on myocardial steatosis and cardiac remodeling in patients with newly diagnosed type 2 diabetes: a longitudinal study
Rosales-Rojas, A, Teis, A, Gil-Millan, P, Rossell, J, Pedraz-Petrozzi, B, Vilades, D, Sanchez-Quesada, JL, García-Osuna, A, Mauricio, D, Julve, J, Perez, A, Alonso, N. Impact of glycemic optimization on myocardial steatosis and cardiac remodeling in patients with newly diagnosed type 2 diabetes: a longitudinal study. Cardiovascular Diabetology. 2026; 25(1)DOI:10.1186/s12933-026-03105-3. PMID:41792715. IF:10.600(Q1/1D).
06/03/2026
Erectile dysfunction, type 2 diabetes, and cardiovascular disease: a narrative review and insights from a global real-world cohort analysis
Mores, SM, Franch-Nadal, J, Mauricio, D, Vlacho, B. Erectile dysfunction, type 2 diabetes, and cardiovascular disease: a narrative review and insights from a global real-world cohort analysis. Frontiers In Clinical Diabetes And Healthcare. 2026; 7DOI:10.3389/fcdhc.2026.1781581. PMID:41867241. IF:(Q/D).
04/03/2026
Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial
Català-Moll, F, Blázquez-Bondia, C, Farré-Badia, J, Torres, F, Manzardo, C, Bonfill, E, Curran, A, Domingo, P, Podzamczer, D, Force, L, Falcó, V, Parera, M, Casadellà, M, Miró, JM, Noguera-Julian, M, Paredes, R. Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial. Nature Communications. 2026; 17(1)DOI:10.1038/s41467-026-69846-7. PMID:41781390. IF:15.700(Q1/1D).